Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Rietscher, RenéCzaplewska, Justyna A
Majdanski, Tobias C
Gottschaldt, Michael
Schubert, Ulrich S
Schneider, Marc
Lehr, Claus-Michael
Issue Date
2016-03-16
Metadata
Show full item recordAbstract
The effect of modifying the well-established pharmaceutical polymer PLGA by different PEG-containing block-copolymers on the preparation of ovalbumin (OVA) loaded PLGA nanoparticles (NPs) was studied. The used polymers contained poly(d,l-lactic-co-glycolic acid) (PLGA), polyethylene glycol (PEG) and poly(allyl glycidyl ether) (PAGE) as building blocks. The double emulsion technique yielded spherical NPs in the size range from 170 to 220nm (PDI<0.15) for all the differently modified polymers, allowing to directly compare protein loading of and release. PEGylation is usually believed to increase the hydrophilic character of produced particles, favoring encapsulation of hydrophilic substances. However, in this study simple PEGylation of PLGA had only a slight effect on protein release. In contrast, incorporating a PAGE block between the PEG and PLGA units, also eventually enabling active targeting introducing a reactive group, led to a significantly higher loading (+25%) and release rate (+100%), compared to PLGA and PEG-b-PLGA NPs.Citation
Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release. 2016, 500 (1-2):187-95 Int J PharmPubMed ID
26784983Type
ArticleLanguage
enISSN
1873-3476ae974a485f413a2113503eed53cd6c53
10.1016/j.ijpharm.2016.01.021
Scopus Count
The following license files are associated with this item:
Related articles
- Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
- Authors: Rietscher R, Schröder M, Janke J, Czaplewska J, Gottschaldt M, Scherließ R, Hanefeld A, Schubert US, Schneider M, Knolle PA, Lehr CM
- Issue date: 2016 May
- Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
- Authors: Liu R, Wang Y, Li X, Bao W, Xia G, Chen W, Cheng J, Xu Y, Guo L, Chen B
- Issue date: 2015
- PEGylation strategies for active targeting of PLA/PLGA nanoparticles.
- Authors: Betancourt T, Byrne JD, Sunaryo N, Crowder SW, Kadapakkam M, Patel S, Casciato S, Brannon-Peppas L
- Issue date: 2009 Oct
- Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
- Authors: Lin TsT, Gao DY, Liu YC, Sung YC, Wan D, Liu JY, Chiang T, Wang L, Chen Y
- Issue date: 2016 Jan 10
- Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
- Authors: Li Z, Huang H, Huang L, Du L, Sun Y, Duan Y
- Issue date: 2017 Apr 13